24. DIAGNOSIS TREE FOR PROSTATE CANCER IN MEN OVER 50 YEARS OF DEVELOPMENT AT MEDIC MEDICAL CENTER

Nguyen Chi Cuong1, Nguyen Minh Thien1, Nguyen Truong Vien2, Ho Hoang Vu3, Tran Ngoc Dang3, Huynh Nghia3, To Gia Kien3
1 MEDIC Medical Center
2 Pham Ngoc Thach University of Medicine
3 University of Medicine and Pharmacy at Ho Chi Minh

Main Article Content

Abstract

Introduction: Prostate cancer diagnosis (PCa) has potential for improvement through algorithms combining clinical and paraclinical information. This study aims to develop a PCa diagnostic tree based on data from men over 50 with biopsy indications.


Methods: A cross-sectional study was conducted at the MEDIC Medical Center from 2020 to 2023. Retrospective records of men ≥50 with lower urinary tract symptoms and biopsy indications were analyzed. Patients who were indicated for biopsy due to suspected PCa via digital rectal examination (DRE) or tPSA≥4ng/ml according to Vietnam Ministry of Health guidelines were selected, excluding cases with concurrent other cancers.


Results: The diagnostic tree based on tPSA, DRE, TRUS achieved stable performance on both training and internal validation sets with sensitivity over 90%, specificity over 70%, positive predictive value over 70%, negative predictive value over 95%, and accuracy over 80%. ư


Conclusion: The developed diagnostic tree ensures reliability and practical applicability in clinical settings. Furthermore, TRUS makes a greater contribution than MRI in the diagnostic tree of PCa, and the simultaneous use of TRUS and MRI may not be necessary.

Article Details

References

[1] Bộ Y tế, Hướng dẫn chẩn đoán và điều trị ung thư tuyến tiền liệt. Quyết định số 3130/QĐ-BYT. 2020:tr.4-7.
[2] Hội Tiết Niệu và Thận học Việt Nam, Phác đồ hướng dẫn chẩn đoán và điều trị ung thư tuyến tiền liệt, 2020.
[3] Keeney, S S, M MR, et al., Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial. Pharmacoeconomics. Dec 2022;40(12):1207-1220. doi:10.1007/s40273-022-01191-1
[4] American Cancer Society, Prostate cancer: Early Detection, Diagnosis, and Staging. https://www.cancer.org/cancer/prostate-cancer/detection-diagnosis-staging/, Accessed access on 27Feb2021.
[5] Võ Hiếu Thành, Nguyễn Minh Thiền, Phan Thanh Hải, Tương quan mô bệnh học và tổn thương PI-RADS (3,4,5) phiên bản 2: Hồi cứu 47 trường hợp. Vol. 22. 2018:115. Chuyên đề Hội nghị KHKT Bệnh viện Bình Dân.
[6] Vũ Lê Chuyên, Đào Quang Oánh, Đỗ Anh Toàn, Khảo sát tỷ lệ ung thư tuyến tiền liệt ở nam giới trên 50 tuổi đến khám tại bệnh viện Bình Dân, X., 16 (2012) tr. 335-342. Y Học TP Hồ Chí Minh. 2012;16:tr. 335-342.
[7] Garzotto M, Beer TM, Hudson RG et al., Improved detection of prostate cancer using classification and regression tree analysis. J Clin
Oncol. Jul 1 2005;23(19):4322-9. doi:10.1200/JCO.2005.11.136
[8] Boesen L, Nørgaard N, Løgager V et al., Prebiopsy Biparametric Magnetic Resonance Imaging Combined with Prostate-specific Antigen Density in Detecting and Ruling out Gleason 7-10 Prostate Cancer in Biopsy-naïve Men. Eur Urol Oncol. May 2019;2(3):311-319. doi:10.1016/j.euo.2018.09.001